These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 15100125)

  • 1. Small (Kim KW; Kim AY; Kim TK; Park SH; Kim HJ; Lee YK; Park MS; Ha HK; Kim PN; Kim JC; Lee MG
    AJR Am J Roentgenol; 2004 May; 182(5):1233-40. PubMed ID: 15100125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients.
    Kim HJ; Kim KW; Byun JH; Won HJ; Shin YM; Kim PN; Lee MS; Lee MG
    AJR Am J Roentgenol; 2006 Apr; 186(4):1059-66. PubMed ID: 16554579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma.
    Regge D; Campanella D; Anselmetti GC; Cirillo S; Gallo TM; Muratore A; Capussotti L; Galatola G; Floriani I; Aglietta M
    Clin Radiol; 2006 Apr; 61(4):338-47. PubMed ID: 16546464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
    Rockall AG; Planche K; Power N; Nowosinska E; Monson JP; Grossman AB; Reznek RH
    Neuroendocrinology; 2009; 89(3):288-95. PubMed ID: 19023191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].
    Grimm J; Müller-Hülsbeck S; Blume J; Biederer J; Heller M
    Rofo; 2001 Mar; 173(3):266-72. PubMed ID: 11293872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of liver metastases in colorectal cancer on chemotherapy. Comparative study between MRI with teslascan and computed tomography with intravenous contrast media].
    Beziat C; Pilleul F; Yzebe D; Lombard-Bohas C; Mercier C; Valette PJ
    J Radiol; 2004 Mar; 85(3):307-11. PubMed ID: 15192523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT.
    Bartolozzi C; Donati F; Cioni D; Procacci C; Morana G; Chiesa A; Grazioli L; Cittadini G; Cittadini G; Giovagnoni A; Gandini G; Maass J; Lencioni R
    Eur Radiol; 2004 Jan; 14(1):14-20. PubMed ID: 14730384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of rim and segmental MRI enhancement of colorectal hepatic metastasis after administration of mangafodipir trisodium.
    Koh DM; Brown G; Meer Z; Norman AR; Husband JE
    AJR Am J Roentgenol; 2007 Feb; 188(2):W154-61. PubMed ID: 17242222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
    Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R
    Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.
    Schima W; Függer R; Schober E; Oettl C; Wamser P; Grabenwöger F; Ryan JM; Novacek G
    AJR Am J Roentgenol; 2002 Sep; 179(3):717-24. PubMed ID: 12185052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of hepatic metastasis: manganese- and ferucarbotran-enhanced MR imaging.
    Choi JY; Kim MJ; Kim JH; Kim SH; Ko HK; Lim JS; Oh YT; Chung JJ; Yoo HS; Lee JT; Kim KW
    Eur J Radiol; 2006 Oct; 60(1):84-90. PubMed ID: 16920315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 mumol/kg body weight in detecting focal liver tumors: results of a phase III trial using an infusion technique.
    Padovani B; Lecesne R; Raffaelli C; Chevallier P; Drouillard J; Bruneton JN; Lambrechts M; Gordon P
    Eur J Radiol; 1996 Nov; 23(3):205-11. PubMed ID: 9003926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver lesions: manganese-enhanced MR and dual-phase helical CT for preoperative detection and characterization comparison with receiver operating characteristic analysis.
    Braga HJ; Choti MA; Lee VS; Paulson EK; Siegelman ES; Bluemke DA
    Radiology; 2002 May; 223(2):525-31. PubMed ID: 11997563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT.
    Oudkerk M; Torres CG; Song B; König M; Grimm J; Fernandez-Cuadrado J; Op de Beeck B; Marquardt M; van Dijk P; de Groot JC
    Radiology; 2002 May; 223(2):517-24. PubMed ID: 11997562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool.
    Helmberger TK; Laubenberger J; Rummeny E; Jung G; Sievers K; Döhring W; Meurer K; Reiser MF
    Eur Radiol; 2002 Jan; 12(1):62-70. PubMed ID: 11868075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Focal secondary malignant liver lesions: MnDPDP-enhanced MRT at 0.2 tesla vs. helical CT-arterioportography].
    Rieger J; Körner M; Linsenmaier U; Rock C; Wirth S; Pfeifer KJ
    Rofo; 2002 Nov; 174(11):1402-7. PubMed ID: 12424667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging.
    Federle M; Chezmar J; Rubin DL; Weinreb J; Freeny P; Schmiedl UP; Brown JJ; Borrello JA; Lee JK; Semelka RC; Mattrey R; Dachman AH; Saini S; Harms SE; Mitchell DG; Anderson MW; Halford HH; Bennett WF; Young SW; Rifkin M; Gay SB; Ballerini R; Sherwin PF; Robison RO
    J Magn Reson Imaging; 2000 Nov; 12(5):689-701. PubMed ID: 11050638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Kim MJ; Kim JH; Lim JS; Oh YT; Chung JJ; Choi JS; Lee WJ; Kim KW
    J Magn Reson Imaging; 2004 Oct; 20(4):612-21. PubMed ID: 15390224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
    Sahani DV; Kalva SP; Fischman AJ; Kadavigere R; Blake M; Hahn PF; Saini S
    AJR Am J Roentgenol; 2005 Jul; 185(1):239-46. PubMed ID: 15972430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.